Palatin Reports Second Quarter Fiscal Year 2023 Financial Results and Provides Corporate Update
Phase 3 Pivotal Study of PL9643 in Patients with Dry Eye Disease Ongoing Patient Enrollment on Track Topline Results Currently Expected Mid-Calendar Year 2023...
Source: prnewswire.com